Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives ...
CARDIFF, UK / ACCESS Newswire / February 12, 2025 /Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage ...
吉美瑞生肺干细胞产品获FDA孤儿药认定，最新数据在Nature子刊发表
近日，吉美瑞生再生医学集团（Regend Therapeutics）宣布， 美国食品药品监督管理局（FDA）已授予其气道基底层干细胞产品Pulmovinci孤儿药认定（Orphan Drug Designation, ODD） ...
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for ...
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds ...
The Pharma Letter2 天
BIO applauds introduction of bipartisan ORPHAN Cures Act
The ORPHAN Cures Act (HR 946), a bipartisan bill that removes barriers to treating and curing rare diseases, was reintroduced ...
Biodexa Pharmaceuticals PLC: Following Positive Phase 2 Results and Orphan Drug Designation ...
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen ...
Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing
Bioxodes raises €2.7 million from existing investors in Series A extensionInterim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial ...
GlobalData on MSN12 小时
Lundbeck gains FDA fast track designation for MSA therapy amlenetug
The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...